Abbvie Inc stock is traded at $294.83, with a volume of 8,408,076. It is up +3.09% in the last 24 hours and up +12.18% over the past month. AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Previous Close:
$286.00
Open:
$293.95
24h Volume:
8,408,076
Relative Volume:
1.51
Market Cap:
$521.00B
Revenue:
$62.82B
Net Income/Loss:
$3.60B
P/E Ratio:
145.42
EPS:
$2.03
Net Cash Flow:
$19.98B
1W Performance:
+3.09%
1M Performance:
+12.18%
6M Performance:
+41.64%
1Y Performance:
+36.56%
1-Day Range:
$283.32$295.40
1-Week Range:
$283.32$298.74
52-Week Range:
$190.75$298.74
Abbvie Inc Stock (ABBV) Company Profile
Name
Abbvie IncSector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
(847) 932-7900Address
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS